We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

4 hedge funds and large institutions have $4.64M invested in Tiziana Life Sciences in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.07% less ownership

Funds ownership: 3.16% → 3.09% (-0.07%)

20% less funds holding

Funds holding: 5 → 4 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

91% less capital inflows, than outflows

Capital inflows: $8.4K | Capital outflows: $92.6K

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighPoint Advisor Group
HighPoint Advisor Group
Illinois
+$7.76K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$637

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$80K
2
UBS Group
UBS Group
Switzerland
-$9K
3
HighTower Advisors
HighTower Advisors
Illinois
-$3.58K

TLSA Hedge Fund Activity: Q2 2019 in Review

4 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2019, worth a combined $4.64M — up 19% from $3.89M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TLSA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was HighPoint Advisor Group, adding an estimated $7.76K. The largest seller was Citadel Advisors, exiting entirely with an estimated $80K sold.

  • 4 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2019, down from 5 in Q1 2019.
  • Funds reported $4.64M of Tiziana Life Sciences stock for Q2 2019, up 19% quarter-over-quarter.
  • 1 fund opened new Tiziana Life Sciences positions in Q2 2019 and 2 closed out, a net change of -1 holder.
  • The largest Tiziana Life Sciences buyer in Q2 2019 was HighPoint Advisor Group, an estimated $7.76K added.
  • The largest Tiziana Life Sciences seller in Q2 2019 was Citadel Advisors, an estimated $80K sold.

Based on aggregated 13F filings for Q2 2019.